CTI BioPharma Corp. CTIC
$ 9.09
0.0%
Quarterly report 2023-Q1
added 05-15-2023
Country |
USA |
IPO year |
1997 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Dr. Adam R. Craig |
Employees in the company |
25 |
Shares |
115 M |
Market Cap[1] |
$ 1.2 B |
EBITDA (LTM) |
$ -72.3 M |
P/E (LTM) |
-11.02 |
P/S (LTM) |
20.67 |
EPS (LTM) |
-0.81 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.